![]() Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. | |||
Founding Date | Founding Date 1996 | Founding Date 2002 | Founding Date 2013 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Saint-Quentin-Fallavier, FR HQ | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more | Locations South San Francisco, US HQ |
Employees | Employees 2272% increase | Employees 58415% increase | Employees 11914% increase |
Financial | |||
Revenue (est.) | Revenue (est.) £95.9m (FY, 2015) | Revenue (est.) $528.3m (FY, 2024) | Revenue (est.) N/A |
Cost of goods | Cost of goods £43.1m (FY, 2015) | Cost of goods $52.9m (FY, 2024) | Cost of goods N/A |
Gross profit | Gross profit £52.8m (FY, 2015) | Gross profit $475.4m (FY, 2024) | Gross profit N/A |
Net income | Net income N/A | Net income ($56.1m) (FY, 2024) | Net income ($176.6m) (FY, 2021) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 88m | Total funding raised $ 157m |
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View companyTricida operates in the healthcare industry focusing on pharmaceutical business.
View company